| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 13 | +69.23% | -4.33% | -0.83% | -3.50% | -3.19% | — |
| 14d | 13 | +61.54% | -5.88% | -1.67% | -4.21% | -2.25% | — |
| 30d | 13 | +61.54% | -6.19% | -0.56% | -5.63% | -6.74% | — |
| 60d | 13 | +76.92% | -9.23% | +0.40% | -9.64% | -14.82% | — |
| 90d | 13 | +69.23% | -14.03% | +2.77% | -16.81% | -25.30% | — |
| 180d | 13(1 pending) | +83.33% | -21.59% | +4.80% | -26.39% | -17.47% | — |
| 1y | 13(1 pending) | +75.00% | -33.72% | +10.92% | -44.65% | -49.85% | — |
| 2y | 13(1 pending) | +100.00% | -75.19% | +31.00% | -106.19% | -108.32% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VSTM VERASTEM, INC. | PURCHASEGRANT Stock grant | 36,000 | — | — | 52,666 | May 21, 2026 | May 26, 2026 ↗ | View → |
| GERN GERON CORP | SALE EVP, CHIEF FINANCIAL OFFICER | 27,500 | — | — | 82,500 | Feb 18, 2026 | Feb 19, 2026 ↗ | View → |
| GERN GERON CORP | PURCHASE EVP, CHIEF FINANCIAL OFFICER | 27,500 | — | — | 27,500 | Feb 18, 2026 | Feb 19, 2026 ↗ | View → |
| GERN GERON CORP | SALE EVP, CHIEF FINANCIAL OFFICER | 9,855 | $1.94 | $19.1K | 17,645 | Feb 18, 2026 | Feb 19, 2026 ↗ | View → |
| GERN GERON CORP | PURCHASEGRANT Stock grant | 1,660,000 | — | — | 1,660,000 | Feb 17, 2026 | Feb 19, 2026 ↗ | View → |
| VSTM VERASTEM, INC. | PURCHASEGRANT Stock grant | 12,500 | — | — | 12,500 | May 22, 2025 | May 27, 2025 ↗ | View → |
| VSTM VERASTEM, INC. | PURCHASEGRANT Stock grant | 8,333 | — | — | 16,666 | May 22, 2025 | May 27, 2025 ↗ | View → |
| GERN GERON CORP | PURCHASEGRANT Stock grant | 110,000 | — | — | 110,000 | Feb 18, 2025 | Feb 20, 2025 ↗ | View → |
| GERN GERON CORP | PURCHASEGRANT Stock grant | 656,000 | — | — | 656,000 | Feb 18, 2025 | Feb 20, 2025 ↗ | View → |
| VSTM VERASTEM, INC. | PURCHASEGRANT Stock grant | 12,500 | — | — | 12,500 | Jun 18, 2024 | Jun 20, 2024 ↗ | View → |
| VSTM VERASTEM, INC. | PURCHASEGRANT Stock grant | 8,333 | — | — | 8,333 | Jun 18, 2024 | Jun 20, 2024 ↗ | View → |
| GERN GERON CORP | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Jun 6, 2024 | Jun 7, 2024 ↗ | View → |
| VSTM VERASTEM, INC. | SALE | 5,291 | — | — | 0 | Mar 11, 2024 | Mar 13, 2024 ↗ | View → |
| VSTM VERASTEM, INC. | PURCHASEGRANT Stock grant | 5,291 | — | — | 5,291 | Mar 11, 2024 | Mar 13, 2024 ↗ | View → |
| GERN GERON CORP | PURCHASEGRANT Stock grant | 850,000 | — | — | 850,000 | Feb 14, 2024 | Feb 16, 2024 ↗ | View → |
| GERN GERON CORP | PURCHASEGRANT Stock grant | 1,350,000 | — | — | 1,350,000 | Sep 25, 2023 | Sep 27, 2023 ↗ | View → |
| VSTM VERASTEM, INC. | PURCHASEGRANT Stock grant | 62,500 | — | — | 62,500 | May 15, 2023 | May 16, 2023 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE10b5-1 10b5-1 plan | 949 | $9.87 | $9.4K | 106,610 | May 11, 2023 | May 15, 2023 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE EVP, CHIEF FINANCIAL OFFICER | 184 | $8.89 | $1.6K | 107,559 | Mar 3, 2023 | Mar 6, 2023 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | PURCHASEGRANT Stock grant | 31,500 | — | — | 107,743 | Mar 2, 2023 | Mar 6, 2023 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | PURCHASEGRANT Stock grant | 94,500 | — | — | 94,500 | Mar 2, 2023 | Mar 6, 2023 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE EVP, CHIEF FINANCIAL OFFICER | 4,287 | $9.67 | $41.4K | 76,243 | Feb 13, 2023 | Feb 15, 2023 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE EVP, CHIEF FINANCIAL OFFICER | 1,752 | $8.16 | $14.3K | 80,530 | Jan 10, 2023 | Jan 12, 2023 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE EVP, CHIEF FINANCIAL OFFICER | 193 | $10.23 | $2.0K | 82,282 | Dec 5, 2022 | Dec 6, 2022 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE EVP, CHIEF FINANCIAL OFFICER | 192 | $15.01 | $2.9K | 82,475 | Sep 6, 2022 | Sep 8, 2022 ↗ | View → |
| VSTM VERASTEM, INC. | PURCHASEGRANT Stock grant | 62,500 | — | — | 62,500 | Jun 22, 2022 | Jun 24, 2022 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE EVP, CHIEF FINANCIAL OFFICER | 1,527 | $11.54 | $17.6K | 82,667 | Jun 3, 2022 | Jun 6, 2022 ↗ | View → |
| VSTM VERASTEM, INC. | PURCHASEGRANT Stock grant | 62,500 | — | — | 62,500 | May 12, 2022 | Dec 20, 2022 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE EVP, CHIEF FINANCIAL OFFICER | 767 | $17.33 | $13.3K | 84,194 | Mar 3, 2022 | Mar 7, 2022 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | PURCHASEGRANT Stock grant | 53,499 | — | — | 84,961 | Feb 10, 2022 | Feb 11, 2022 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | PURCHASEGRANT Stock grant | 157,580 | — | — | 157,580 | Feb 10, 2022 | Feb 11, 2022 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE Chief Financial Officer | 1,744 | $25.70 | $44.8K | 31,462 | Jan 11, 2022 | Jan 13, 2022 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | PURCHASEGRANT Stock grant | 4,471 | — | — | 33,206 | Dec 22, 2021 | Dec 23, 2021 ↗ | View → |
| VSTM VERASTEM, INC. | PURCHASEGRANT Stock grant | 63,493 | — | — | 63,493 | Nov 15, 2021 | Nov 17, 2021 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | PURCHASE Chief Financial Officer | 2,500 | $30.65 | $76.6K | 31,235 | Aug 9, 2021 | Aug 10, 2021 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE Chief Financial Officer | 2,500 | $60.00 | $150.0K | 28,735 | Aug 9, 2021 | Aug 10, 2021 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE Chief Financial Officer | 2,500 | — | — | 115,000 | Aug 9, 2021 | Aug 10, 2021 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE Chief Financial Officer | 2,500 | $50.00 | $125.0K | 28,735 | Jun 28, 2021 | Jun 29, 2021 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | PURCHASE Chief Financial Officer | 2,500 | $30.65 | $76.6K | 31,235 | Jun 28, 2021 | Jun 29, 2021 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE Chief Financial Officer | 2,500 | — | — | 117,500 | Jun 28, 2021 | Jun 29, 2021 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | PURCHASEGRANT Stock grant | 10,303 | — | — | 28,735 | Mar 2, 2021 | Mar 4, 2021 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | PURCHASEGRANT Stock grant | 32,197 | — | — | 32,197 | Mar 2, 2021 | Mar 4, 2021 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | SALE Chief Financial Officer | 1,568 | $78.27 | $122.7K | 18,432 | Jan 12, 2021 | Jan 13, 2021 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | Jan 9, 2020 | Jan 10, 2020 ↗ | View → |
| EDIT EDITAS MEDICINE, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Jan 9, 2020 | Jan 10, 2020 ↗ | View → |